C3J Therapeutics   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Inglewood CA United States (2005)
Status: Acquired by AmpliPhi Biosciences Corporation (2019)

Organization Overview

First Clinical Trial
2014
NCT02044081
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Mergers & Acquisitions

Historical Acquisition Tree